QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS5-Region Domestic Shipping
What is Tirzepatide??
Tirzepatide (LY3298176, CAS 2023788-19-2) is a 39-amino acid synthetic twincretin simultaneously activating both GIPR and GLP-1R. This 90mg/vial format supports high-dose preclinical studies, concentration-response comparisons, and multi-arm metabolic experiments requiring larger tirzepatide quantities. It incorporates a C18 fatty diacid for albumin binding (~5-day half-life), enabling sustained dual incretin receptor stimulation for extended research windows.
Research Applications
High-Dose Dual Incretin Research
Dose-escalation GIPR+GLP-1R activation at 90mg/vial — concentration-response profiling
Obesity Models
Severe diet-induced obesity, high-fat diet models — larger tirzepatide quantities for multi-week studies
Glucose & Insulin
β-cell mass studies, glucose-stimulated insulin secretion (GSIS), glucagon suppression
Lipid & NAFLD Research
Hepatic steatosis, liver triglyceride reduction, adipose tissue remodelling
Mechanism Profiling
GIP vs. GLP-1 contribution dissection, β-arrestin signalling, incretin receptor desensitisation
Quick Specs
| Form | Lyophilized powder |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | 2023788-19-2 |
| Also Known As | LY3298176, Mounjaro® active peptide |
| Molecular Weight | ~4813 Da |
| Half-Life | ~5 days (C18 fatty diacid albumin binding) |
| Vial Content | 90mg |
| Peptide Type | Synthetic dual GIP/GLP-1 receptor agonist — twincretin |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house Fmoc SPPS — Qingdao, China |
| Storage | -20°C sealed | 2–8°C reconstituted (2–4 weeks) |
| Shelf Life | 24 months unopened |
